The Jackson Laboratory, Northern Light Health and University of Maine are collaborating on the research.
Alzheimer’s disease
Posted inLocal & State
Free Alzheimer’s educational conference to be held in Portland next week
The Alzheimer’s Foundation of America is hosting the conference on June 11 at the Portland Regency.
advertisement
Posted inHealth
Portland man, 74, turns first Boston Marathon into a race to save Alzheimer’s research
Ralph Carmona, a 74-year-old Portland man who has Alzheimer’s, says he is a living example of the value of medical research.
Posted inLocal & State, Nation & World, News
Sen. Collins helps usher another Alzheimer’s bill into law
The Building Our Largest Dementia Infrastructure for Alzheimer’s Reauthorization Act of 2024, which was signed into law Wednesday, renews and expands federal funding opportunities for dementia care and support.
Posted inHealth, Local & State
New laws spearheaded by Sen. Susan Collins extend funding for Alzheimer’s
The effort builds on a 2011 initiative that helped lead to new treatments for the disease.
Posted inHealth, Nation & World, News
Alzheimer’s drug that can slow disease gets backing from FDA advisers
If it wins final approval, the drug, donanemab, would only be the second Alzheimer’s drug cleared in the U.S. that’s been shown to convincingly slow cognitive decline and memory problems due to Alzheimer’s.
Posted inUncategorized
A gene long thought to just raise the risk for Alzheimer’s may cause some cases
Scientists say the research makes it critical to develop treatments that target the APOE4 gene.
Posted inUncategorized
Portland man takes part in drug trial giving new hope in fight against Alzheimer’s disease
Ralph Carmona participated in a clinical research trial for Leqembi, a new Alzheimer’s drug that he believes stopped his symptoms from progressing.
Posted inHealth, Nation & World, News
FDA gives full approval for Alzheimer’s drug Leqembi, and Medicare will pay for it
The Food and Drug Administration endorsed the IV drug, Leqembi, for patients with mild dementia and other symptoms caused by early Alzheimer’s disease.
Posted inHealth, Local & State
Sen. Collins spearheads efforts to fund Alzheimer’s research
A bipartisan group of senators is proposing to boost funding for research and prevention through 2035.